Skip to Main Content

Author Details

Angela Alexander
University of Texas MD Anderson Cancer Center
2004
21
15
PMIDPaper TitleJournal TitlePublished Year
36729801Inflammatory Breast Cancer: Understanding the Patient Experience.Cancer Nurs2024
36729801Inflammatory Breast Cancer: Understanding the Patient Experience.Cancer Nurs2024
37146584Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.Cell Stem Cell2023
37146584Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.Cell Stem Cell2023
34930010"Why and What" for the optimal management of inflammatory breast cancer.Chin Clin Oncol2021
34930010"Why and What" for the optimal management of inflammatory breast cancer.Chin Clin Oncol2021
32970482Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters.JCO Clin Cancer Inform2020
32970482Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters.JCO Clin Cancer Inform2020
29721053Survivorship and Advocacy in Inflammatory Breast Cancer.J Cancer2018
30181387Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.Clin Cancer Res2018
29721054International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.J Cancer2018
29721053Survivorship and Advocacy in Inflammatory Breast Cancer.J Cancer2018
30181387Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.Clin Cancer Res2018
29721054International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.J Cancer2018
28619757CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest.Mol Cancer Ther2017
28619757CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest.Mol Cancer Ther2017
29667990Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10<sup>th</sup> Anniversary Conference.J Cancer2017
28107181Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.Oncotarget2017
28107181Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.Oncotarget2017
29667990Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10<sup>th</sup> Anniversary Conference.J Cancer2017
27182644Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.Am J Pathol2016
27182644Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.Am J Pathol2016
26344566ATM functions at the peroxisome to induce pexophagy in response to ROS.Nat Cell Biol2015
26344566ATM functions at the peroxisome to induce pexophagy in response to ROS.Nat Cell Biol2015
23955302A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.Nat Cell Biol2013
23955302A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.Nat Cell Biol2013
21396365The role of LKB1 and AMPK in cellular responses to stress and damage.FEBS Lett2011
21396365The role of LKB1 and AMPK in cellular responses to stress and damage.FEBS Lett2011
20160076ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.Proc Natl Acad Sci U S A2010
20890104Differential localization of ATM is correlated with activation of distinct downstream signaling pathways.Cell Cycle2010
20160076ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.Proc Natl Acad Sci U S A2010
20581436ATM engages the TSC2/mTORC1 signaling node to regulate autophagy.Autophagy2010
20890104Differential localization of ATM is correlated with activation of distinct downstream signaling pathways.Cell Cycle2010
20581436ATM engages the TSC2/mTORC1 signaling node to regulate autophagy.Autophagy2010
19118035Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.Clin Cancer Res2009
19395652PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.Am J Pathol2009
19118035Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.Clin Cancer Res2009
19395652PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.Am J Pathol2009
15043190Type I collagen-mediated changes in gene expression and function of prostate cancer cells.Cancer Treat Res2004
15585835Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands.J Immunol2004
15043190Type I collagen-mediated changes in gene expression and function of prostate cancer cells.Cancer Treat Res2004
15585835Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands.J Immunol2004
  • 1 - 42 of 42

Recommended Authors

Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 3
College of Horticulture, China Agricultural University
Career Start Year 2012
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 1
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Moores Cancer Center, University of California
Career Start Year 2007
Number of shared co-authors 0
The First Affiliated Hospital of Guangdong Pharmaceutical University
Career Start Year 2005
Number of shared co-authors 0
University of Southern California
Career Start Year 2004
Number of shared co-authors 0
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
Western University
Career Start Year 1999
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 3
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 1
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 3
Case Western Reserve University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
University of Toronto
Career Start Year 1988
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 7
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 5
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1987
Number of shared co-authors 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 8
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Weill Cornell School of Medicine
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Jeonbuk National University
Co-authored papers 1
University of Southern California.
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
J. Craig Venter Institute
Co-authored papers 1
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
University of Tubingen
Co-authored papers 1
University of Southern California
Co-authored papers 1
Drew University, National Institutes of Health, Rutgers University New Brunswick, University of North Carolina at Chapel Hill
Co-authored papers 1
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Center for Biomedical Research Support, The University of Texas at Austin
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Keck School of Medicine, University of Southern California
Co-authored papers 1
Dornsife Center for Self-Report Science, University of Southern California
Co-authored papers 1
University of Texas at Austin
Co-authored papers 1
Co-authored papers 1